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In organ transplantation nitric oxide has been reported to be involved in 
allograft rejection. We examined in a rat lung transplantation model 
whether nitric oxide is overproduced in acute rejection and can be detected 
in exhaled air. Thirteen rat right lung transplants were separated into three 
groups: group 1 (n = 5), untreated allografts (Brown-Norway [RT1 ~] to 
Lewis [RTll]); group 2 (n = 4), cyclosporine-treated allografts; and group 
3 (n = 4), isografts (Lewis to Lewis). We examined exhaled nitric oxide 
levels with a chemiluminescence analyzer and chest roentgenograms on 
days 2 through 5. Histologic samples were obtained on days 3 and 5. On day 
5, the recipients were killed and we measured exhaled nitric oxide from the 
right and left lungs separately. Blood samples were also obtained for 
measurement of serum nitrite/nitrate. The exhaled nitric oxide level in 
untreated allografts increased significantly from day 5 (63.9 -- 39.2 ppb, 
p = 0.0095) and was significantly higher than that in treated allografts 
(9.1 - 1.6 ppb) (p = 0.0085) and isografts (6.9 + 0.5 ppb) (p = 0.0068). The 
nitric oxide level in untreated allografts (826.5 -- 416.1 ppb) was 75 times 
as high as that from the contralateral normal left lungs (11.2 -- 2.6 ppb) 
(p = 0.0118). The level of exhaled nitric oxide correlated significantly with 
the histologic rejection grade (p = 0.0001). There was no significant 
difference in the serum nitrite/nitrate levels between a|lografts and 
isografts. These data suggest that increased exhaled nitric oxide levels 
might reflect acute rejection in lung transplants. (J Thorac Cardiovasc 
Surg 1997;113:830-5) 
N itric oxide (NO) has been reported to be in- volved in allograft rejection in experimental 
vascularized organ transplants uch as heart, 1 kid- 
ney, 2 and pancreas? In those reports, NO was 
detected in the serum or urine by measurement of
the stable end products nitrite/nitrate as indirect 
markers of NO in accordance with acute rejection. 
In lung transplantation, Sfiiraishi and colleagues 4 
reported that the serum nitrite/nitrate level in- 
creased during acute rejection and that administra- 
tion of aminoguanidine, an inhibitor of inducible 
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NO synthetase (iNOS), prolonged lung graft sur- 
vival as assessed by radiographic and histologic 
findings. 
Recently endogenous NO, formed in the respira- 
tory system, has been detected in exhaled air from 
human beings 5 and animals 6 in such conditions as 
untreated bronchial asthma and in endotoxin- 
treated rats as a septic model. If the lung itself 
overproduces NO at the time of acute rejection, it is 
hypothesized that NO can be detected in exhaled air 
and the measurement of exhaled NO might work as 
a noninvasive marker of acute rejection. Therefore 
we examined whether NO could be detected in 
exhaled air at acute rejection and whether adminis- 
tration of conventional immunosuppressants could 
suppress the increase in exhaled NO levels. 
Material and methods 
Thirteen orthotopic right single lung transplantation 
procedures were performed with use of weight-matched 
pairs (250 to 350 gm) of male inbred Brown-Norway 
(RTI") and Lewis (RT11) rats purchased from Charles 
River Japan, Inc. (Yokohama). The transplants consisted 
of three groups: group 1 (n = 4), untreated allografts 
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(Brown-Norway to Lewis); group 2 (n = 5), cyclosporine- 
treated allografts (25 mg/kg intramuscularly on days 3 and 
4); and group 3 (n = 4), isograft control transplants (Lewis 
to Lewis). 
Surgical procedure. Right single lung transplantation 
in the rat was performed according to the method de- 
scribed in our previous report. 7 Briefly, the rats were 
anesthetized with intraperitoneal dministration of pen- 
tobarbital (20 mg/kg) after intramuscular injection of 
atropine (0.25 mg/kg) and ketamine (25 mg/kg). The 
donor was placed in the supine position and the lungs 
ventilated with room air through a tracheostomy tube with 
a tidal volume of 10 ml/kg, a respiratory rate of 60 
breaths/min, and a positive end+expiratory pressure of 1.0 
cm H20. Heparin (1000 units/kg) was injected intrave- 
nously and a laparotomy was performed to exsanguinate 
the donors by severing the abdominal aorta and inferior 
vena cava. The thorax was exposed through a median 
sternotomy. Pulmonary arterial flush was not performed. 
The heart-lung block was extracted with the lungs inflated 
at end tidal volume and immersed in 4 ° C saline solution. 
We used a cuff technique for three vascular anastomoses: 
the right main pulmonary artery, a superior pulmonary 
vein, and an inferior pulmonary vein. The dissected right 
lung, with attached cuffs, was preserved in 4°C hepa- 
rinized saline solution until the recipient was prepared. 
The recipient was placed in the left lateral decubitus 
position after orotracheal intubation and a right thoracot- 
omy was performed in the fifth intercostal space. The right 
hilum was dissected and the graft vessels with cuffs were 
anastomosed with circumferential 6-0 silk sutures. The 
right main bronchus was anastomosed with 8-0 Prolene 
polypropylene running suture and the thorax was closed in 
three layers with a chest ube left in place. The chest ube 
and the endotracheal tube were removed after spontane- 
ous ventilation resumed. The animals were set free 
breathing room air. 
Assessment. Preliminary experiments showed this allo- 
graft combination resulted in the completion of allograft 
rejection as assessed roentgenologically b day 7. The 
peak concentration of exhaled NO occurred on day 5 as a 
result of uneven ventilation because of decreasing com- 
pliance of the allograft in accordance with the progression 
of acute rejection. We examined exhaled NO levels and 
the chest radiograph on days 2 through 5. The method of 
NO measurement is described in a following section. On 
day 3, al][ recipients underwent repeat thoracotomy 
through the previous incision and the right upper lobe was 
extracted as a sample for histologic assessment after 
radiographic assessment and measurement of the exhaled 
NO level with inhalation of enflurane. On day 5, the 
recipients 'were killed to obtain the exhaled NO concen- 
tration from both lungs and from the right and left lungs 
separately 30 minutes after circulatory arrest. Blood sam- 
ples were also obtained through an arterial ine. The rest 
of the right lung was extracted for histologic assessment. 
Ventilation score. The lungs in all recipients were 
assessed radiographically each day from days 2 through 5 
before collection of exhaled air; the assessment was done 
according to the ventilation score of Prop and associates 8 
by a blinded coworker. Briefly, scores were determined by 
the sum of the aerated surface score (0 to 3) and the 
density score (0 to 3) of the right lung (6 for normal- 
appearing lungs to 0 for opaque lungs). 
Morphology. For histologic study the right upper lobe 
was removed on day 3 and the lower and postcaval lobes 
were removed on day 5 after collection of the gas samples. 
Specimens were fixed with 20% neutralized formalin. 
Paraffin sections were stained with hematoxylin and eosin 
stain for examination under a light microscope and histo- 
logic rejection grades were scored by a blinded observer 
according to the international working formulation9: 
grade A0, no significant abnormality; grade A1, scattered 
infrequent perivascular mononuclear infiltration; grade 
A2, frequent perivascular mononuclear infiltration; grade 
A3, extension of mononuclear infiltration into alveolar 
septum/spaces; and grade A4, diffuse perivascular, inter- 
stitial, and air space infiltration of mononuclear cells. 
Measurement of exhaled NO. Recipients were placed 
under general anesthesia with inhalation of enflurane and 
intubated with a 14-gauge venous cannula orotracheally. 
Mandatory ventilation consisting of 5 ml of room air was 
done 10 times with a 10 ml syringe. The last 5 ml of 
exhaled air collected in the syringe was subjected to NO 
analysis. Three successive 1 ml exhaled air samples were 
measured with a chemiluminescence analyzer (Sievers 
model 270B) sensitive to NO at concentrations from 5 to 
5 × 105 ppb by volume within 30 minutes after collection 
of exhaled air. The average of the data from the three 
successive samples was used in analysis. 
Measurement of nitrite/nitrate. The 1.5 ml of hepa- 
rinized blood collected at the time the animals were killed 
was centrifuged at 1200g, and the plasma fraction was 
diluted 1:1 with nitrite- and nitrate-free distilled water. 
Subsequently, 400/xl of diluted plasma was ultrafiltered at 
2000g (Ultrafree MC microcentrifuge d vice, UFC3 LGC, 
Millipore, Bedford, Mass.). The filtrates were analyzed by 
an automated procedure based on the Griess reaction] ° 
Statistical analysis. All data are presented as mean 
plus or minus the standard eviation. Analysis of variance 
was used for follow-up of exhaled NO and nitrite/nitrate 
levels. Comparisons of ventilation score and rejection 
grade were analyzed by Mann-Whitney U test. The Spear- 
man rank correlation test was used for analysis between 
exhaled NO level and ventilation score or rejection grade. 
All animals received humane care in compliance with 
recommendations of the National Academy of Sciences. H
Results 
The concentrations of exhaled NO in cyclospor- 
ine-treated allografts and isograffs were consistently 
less than 11 ppb throughout the postoperative days, 
whereas those in untreated allografts increased sig- 
nificantly to day 5 (63.9 _+ 39.2 ppb,p  = 0.0095) and 
these values were significantly higher than those in 
isografts (6.9 +_ 0.5 ppb;p  = 0.0068) and cyclospor- 
ine- treated allografts (9.1 ~+ 1.6 ppb; p = 0.0085) 
(Fig. 1). After exsanguination, exhaled NO levels 
increased both in the untreated allografts from 
63.5 _+ 9.2 ppb to 227.8 _+ 154.8 ppb (p = 0.06) and 
in cyclosporine-treated allografts from 9.1 + 1.6 ppb 
832 Mizuta et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
May 1997 
ppb 
100" 
80' 
60' 
40' 
20" 
0 
-O-  untreated allograft 
- (~-  CsA-treated allograft 
- [ ]  - isograft / 
• • • | 
2 3 4 5 
POD 
Fig. 1. Exhaled NO concentrations from untreated allo- 
grafts (n = 5), cyclosporine (CsA)-treated allografts (n = 
4), and control isografts (n = 4). *Significant difference 
from untreated allografts on postoperative days (POD) 2 
through 4 (p = 0.0095) and on day 5 for isografts (p = 
0.0068) and cyclosporine-treated allografts (p = 0.0085). 
to 16.9 + 3.4 ppb (p = 0.07) (Fig. 2). In the 
untreated allografts the exhaled NO concentration 
from the right lung (826.5 + 416.1 ppb) was 75 times 
as high as that from the left (11.2 _+ 2.6 ppb) (p = 
0.0118). Cyclosporine-treated animals also showed 
significant differences between the NO concentra- 
tions from the right (27.9 _+ 10.6 ppb) and left 
(10.7 _+ 2.9 ppb) grafts (p = 0.0199) (Fig. 3). 
Although the ventilation score significantly de- 
creased from day 3 (4.8 _+ 0.8) (p = 0.005) and day 
4 (4.0 _+ 1.1) (p = 0.0182) to day 5 (3.0 _+ 0.0) in the 
untreated allografts, there was no statistical corre- 
lation between the value of exhaled NO and the 
ventilation score in either untreated or treated 
allografts (Fig. 4). In co'ntrast, he histologic rejec- 
tion grade of untreated allografts ignificantly in- 
creased from day 3 (1.2 _+ 0.5) to day 5 (2.4 + 0.6) 
(p = 0.0139) and the concentration of exhaled NO 
in both untreated and treated allografts correlated 
significantly with the progression of acute rejection 
(p = 0.0001) (Fig. 5, B). There was no significant 
difference in the serum nitrite/nitrate l vels among 
untreated allografts (33.4 _+ 8.2/zmol/L), cyclospor- 
ine-treated allografts (45.5 + 14.8 /xmol/L), and 
isografts (25.4 +_ 6.2 txmol/L) (Fig. 6). 
Discussion 
NO production during allograft rejection has 
been reported in various organs such as heart, t 
kidney, 2 and pancreas 3 and in lung transplantation 
in the rat 4 by measurement of systemic nitrite/ 
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Fig. 2. Changes in exhaled NO concentrations in un- 
treated (closed circles, n = 4) and cyclosporine (CsA)- 
treated (open circles, n = 4) allografts before and after the 
animals were killed. *p = 0.06; **p = 0.07 versus before 
death. 
nitrate, which are stable end products, in serum or 
urine at serial times after transplantation. Endoge- 
nous NO is immediately metabolized by binding to 
hemoglobin or oxygenation and its half life is only a 
few seconds in the physiologic ondition. That is why 
the stable end products have been measured instead 
of NO itself. In this report, with use of a unilateral 
rat lung transplantation model, we were able to 
measure the concentration of NO exhaled from the 
allograft. The concentration of exhaled NO in- 
creased in accordance with the progression of acute 
rejection. There was no increase in exhaled NO 
levels in rats given a conventional immunosuppres- 
sant (Fig. 1). After exsanguination, NO concentra- 
tions in exhaled air increased threefold, reflecting 
the absence of the pulmonary circulation, which 
washes out the produced NO (p -- 0.06). The 
concentration of exhaled NO from the grafts was 
significantly higher than that from the native left 
lungs. These findings imply that the source of pro- 
duced NO was the lungs themselves and especially 
that most of the NO-producing sites were allografts 
undergoing acute rejection. 
Shiraishi and colleagues 4 reported a significant 
increase in concentration of serum nitrite/nitrate on 
days 4 and 7 with orthotopic left lung transplanta- 
tion in a Brown-Norway to F344 (RT1 lvl) rat com- 
bination. Interestingly, in the present study there 
was no significant difference in nitrite/nitrate l vels 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 5 
Mizuta et al. 8 3 3 
pPb m 
800 1 
600 
400 
200 
0 
Rt Lt 
untreated 
Rt Lt 
CsA-treated 
Fig. 3. Exhaled NO concentrations from right (Rt) and 
left (LO lungs in untreated (solid bars, n = 5) and 
cyclosporine (CsA)-treated (open bars, n = 4) allografts. 
*p = 0.0118; **p = 0.0199 versus left lungs. 
among tJ~e isografts control and cyclosporine- 
treated and untreated groups. The difference from 
the previous study may have been caused by the 
different ,;train combination. Also, it is conceivable 
that in hmg transplantation a significant part of 
endogenous NO is lost through ventilation instead 
of degrading to nitrite/nitrate as in other types of 
organ transplantation. Because we used right in- 
stead of left lung transplantation, the loss of NO by 
ventilation from the right lungs may have been more 
efficient han that from the left because the right 
lung has 1.5 times as much volume as the left. 
The ceil sources of NO production in grafts are 
not clear in this study. In rat renal transplantation, 
Cattell and associates lmfound that the localization 
of iNOS in the rejecting grafts was detected in 
infiltrating mononuclear cells in the glomeruli and 
interstitium of rejecting kidney by immunohisto- 
chemistry and that the great majority of interstitial 
mononudear cells in diffuse infiltrates were macro- 
phages. In the respiratory tract, NOS can be induced 
in various superficial cells, including macrophages, 
epithelial cells, and infiltrating inflammatory cells. 
In rat sepsis models treated by intravenous admin- 
istration of endotoxin, anti-iNOS labeled activated 
rat macrophages strongly. 13 Those authors also re- 
ported that one type of NOS that shares epitopes 
with iNOS in macrophages is present constitutively 
in bronchial epithelium. 13Although it is possible 
that NO produced by the bronchial epithelial cells 
also plays a role in lung allograft rejection, the 
amount of NO produced via the constitutive path- 
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Fig. 4. A, Ventilation scores of untreated (closed circles, 
n = 5) and cyclosporine-treated (open circles, n = 4) 
allografts. *p = 0.005; **p = 0.0182 versus day 5 in 
untreated allografts; ***p = 0.0281 versus day 5 in 
untreated allografts, pod, Postoperative day. B, No signif- 
icant correlation was seen between ventilation score and 
the concentrations of exhaled NO. 
way can be rather small compared with that pro- 
duced via the inducible pathway. In chronic rejec- 
tion of lung allografts, however, alloimmunoreactive 
sites are focused in the bronchial epithelium, espe- 
cially in bronchioles as the most important site of 
bronchiolitis obliterans. A further study is underway 
to determine the localization of iNOS in chronic and 
in acute rejection. 
In allograft rejection, the role of NO production 
still remains to be defined. In an in vitro study, 
Hoffmann and coworkers 14 reported that prolifera- 
tion of rat splenocytes was inhibited by a high level 
of nitrite/nitrate in the culture supernatants and that 
this inhibition was reversed by addition of N % 
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Fig. 5. A, Histologic rejection grade of untreated (closed circles, n = 5) and cyclosporine-treated (open 
circles, n = 4) allografts. *p = 0.0139 versus day 3 in untreated allografts, pod, Postoperative day. B, 
Correlation between rejection grade and the concentrations of exhaled NO. p = 0.0001 with Spearman's 
correlation coefficient by rank. 
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Fig. 6. Serum nitrite/nitrate concentrations in untreated 
allografts (n = 5), cyclosporine (CsA)-treated allografts 
(n = 4), and control isografts (n = 4). There were no 
significant differences among groups. 
monomethyl-L-arginine, thecompetitive inhibitor of 
NOS. In contrast, Worrall and associates 15found in 
an in vivo study that treatment with aminoguani- 
dine, the preferential inhibitor of iNOS, prolonged 
graft survival in rat heart transplantation, reduced 
the histologic rejection grades, and inhibited the 
increase in systemic serum nitrite/nitrate Levels. In 
rat lung transplantation, Shiraishi and colleagues 4 
also reported that administration of aminoguanidine 
prolonged graft survival and attenuated histologic 
rejection grades and serum nitrite/nitrate l vels. On 
the other hand, although NO inhalation therapy for 
injured lung during the immediate posttransplanta- 
tion stage has been recommended, 16 there has not 
been any report that inhalation of NO accelerates 
acute lung rejection. Whether NO produced in the 
rejecting raft is cytoprotective or cytotoxic is still a 
matter of controversy. 
In clinical lung transplantation, diagnosis of acute 
rejection is one of the most important subjects. It 
has been common to use clinical findings such as 
deterioration i arterial oxygenation, fever, increas- 
ing fatigue, and radiographic nfiltrates or hilar flare 
to detect acute rejection, iv Therefore we studied 
whether the ventilation score as a clinical standard 
and the histologic rejection grade as the gold stan- 
dard for diagnosis of rejection correlated with the 
level of exhaled NO in untreated and cyclosporine- 
treated allografts. There was no significant correla- 
tion between the ventilation score and the concen- 
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trations of exhaled NO because some grafts on early 
postoperative days showed decreased aeration and 
density caused not by the progression of allograft 
rejection but by reperfusion injury, atelectasis, or 
retention of plural effusion. This was suggested by 
the findings at rethoracotomy and determination of
histologic rejection grade; that is, all allografts 
showed grade A1 rejection except for one recipient 
that showed grade A2 on day 3 (Fig. 5,A). However, 
the concentration of exhaled NO significantly corre- 
lated with the progression of allograft rejection 
assessed by histologic study (Fig. 5, B). This suggests 
that exhaled NO could be a useful marker for 
allograft rejection in lung transplantation. However, 
we must realize that various situations that compro- 
mise the respiratory tract such as infection, inflam- 
matory reactions, and rejection should be differen- 
tiated in the clinical setting. 
Despite these limitations, measurement of the 
level of NO in exhaled air is noninvasive and rapid 
and could be considered a useful method to detect 
and follow up allograft rejection before the use of a 
more invasive measure Such as transbronchial or 
open lung biopsy in the clinical setting. 
REFERENCES 
1. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide 
production in host-versus-graft nd graft-versus-host reac- 
tions in the rat. J Clin Invest 1992;90:679-83. 
2. Winlaw DS, Schyvens CG, Smythe GA, et al. Urinary nitrate 
excretion is a noninvasive indicator of acute cardiac allograft 
rejection and nitric oxide production in the rat. Transplanta- 
tion 1994;58:1031-6. 
3. Tanaka S, Kamiike W, Ito S, et al. Generation of nitric oxide 
as a rejection marker in rat pancreas transplantation. Trans- 
plantation 1995;60:713-7. 
4. Shiraishi T, DeMeester SR, Worrall NK, et al. Inhibition of 
inducible nitric oxide synthase ameliorates rat lung allograft 
rejection. J Thorac Cardiovasc Surg 1995;110:1449-60. 
5. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, 
Shinebourne EA, Barnes PJ. Increased nitric oxide in ex- 
haled air of asthmatic patients. Lancet 1994;343:133-5. 
6. Stewart TE, Valenza F, Ribeiro SP, et al. Increased nitric 
oxide in exhaled gas as an early marker of lung inflammation 
in a model of sepsis. Am J Respir Crit Care Med 1995;151: 
713-8. 
7. Mizuta T, Nakahara K, Matsumura A, Minami M, Yoon HE, 
Matsuda H. Comparison of early postoperative h modynam- 
ics of left and right single lung transplants after contralateral 
pulmonary artery ligation in the rat. Transplant Proc 1995; 
27:585-6. 
8. Prop JM, Ehrie MG, Crapo JD, et al. Reimplantation 
response in isografted rat lungs: analysis of causal factors. 
J Thorac Cardiovasc Surg 1984;87:702-11. 
9. Yousem SA, Berry GJ, Brunt EM, et al. A working formu- 
lation for the standardization f nomenclature in the diag- 
nosis of heart and lung rejection: Lung Rejection Study 
Group. J Heart Lung Transplant 1990;9:593-601. 
10. Green LC, Wagner DA, Glogowski J, et al. Analysis of 
nitrate, nitrite and [15N]nitrate in biological fluids. Anal 
Biochem 1982;126:i31-8. 
11. National Academy of Sciences. Guide for the care and use of 
laboratory animals. Bethesda, Maryland: National Institutes 
of Health. NIH publication No. 86-23, revised 1985. 
12. Cattell V, Smith J, Jansen A, Moreno VR, Moncada S. 
Localization of inducible nitric oxide synthase in acute renal 
allograft rejection in the rat. Transplantation 1994;58:1399- 
402. 
13. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide 
synthase in human and rat lung: immunocytochemical and 
histochemical localization. Am J Respir Cell Mol Biol 1993; 
9:371-7. 
14. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmon 
RL. Alloantigen-induced activation of rat splenocytes is 
regulated by the oxidative metabolism of L-arginine. J Immu- 
nol 1990;145:2220-6. 
15. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in 
vivo alloreactivity by inhibition of inducible nitric oxide 
synthase. J Exp Med 1995;181:63-70. 
16. Date H, Triantafillou AN, Trulock EP, et al. Inhaled nitric 
oxide reduces human lung allograft dysfunction. J Thorac 
Cardiovasc Surg 1996;111:913-9. 
17. Cooper JD, Patterson GA, Trulock EP, et al. Results of 
single and bilateral ung transplantation i  131 consecutive 
recipients. J Thorac Cardiovasc Surg 1994;107:460-71. 
